NO855342L - Pyridoyrimidiner og fremgangsmaater for fremstilling derav. - Google Patents

Pyridoyrimidiner og fremgangsmaater for fremstilling derav.

Info

Publication number
NO855342L
NO855342L NO855342A NO855342A NO855342L NO 855342 L NO855342 L NO 855342L NO 855342 A NO855342 A NO 855342A NO 855342 A NO855342 A NO 855342A NO 855342 L NO855342 L NO 855342L
Authority
NO
Norway
Prior art keywords
pyridoyrimidines
procedures
preparing
pyridopyrimidines
heterocyclic
Prior art date
Application number
NO855342A
Other languages
English (en)
Other versions
NO164353B (no
NO164353C (no
Inventor
Horst Meyer
Egbert Wehinger
Bernward Garthoff
Stanislav Kazda
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO855342L publication Critical patent/NO855342L/no
Publication of NO164353B publication Critical patent/NO164353B/no
Publication of NO164353C publication Critical patent/NO164353C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
NO855342A 1985-01-19 1985-12-30 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner. NO164353C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853501696 DE3501696A1 (de) 1985-01-19 1985-01-19 Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO855342L true NO855342L (no) 1986-07-21
NO164353B NO164353B (no) 1990-06-18
NO164353C NO164353C (no) 1990-09-26

Family

ID=6260235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO855342A NO164353C (no) 1985-01-19 1985-12-30 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridopyrimidiner.

Country Status (18)

Country Link
US (1) US4621082A (no)
EP (1) EP0189045B1 (no)
JP (1) JPS61167688A (no)
CN (1) CN1010947B (no)
AT (1) ATE50407T1 (no)
AU (1) AU578783B2 (no)
CA (1) CA1276636C (no)
DE (2) DE3501696A1 (no)
DK (1) DK23386A (no)
ES (1) ES8704491A1 (no)
FI (1) FI81574C (no)
GR (1) GR860117B (no)
HU (1) HU195812B (no)
NO (1) NO164353C (no)
NZ (1) NZ214842A (no)
PH (1) PH22610A (no)
PT (1) PT81860B (no)
ZA (1) ZA86363B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU598093B2 (en) * 1987-02-07 1990-06-14 Wellcome Foundation Limited, The Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
DK0934937T3 (da) * 1990-11-30 2002-04-02 Otsuka Pharma Co Ltd Azolderivater som superoxidradikalinhibitor
JPH04260503A (ja) * 1991-02-13 1992-09-16 Sekisui Jushi Co Ltd ピッキングシステム
JP3013905B2 (ja) * 1991-06-28 2000-02-28 花王株式会社 自動倉庫の入出庫方法
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US5405848A (en) * 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
US6756367B2 (en) 1998-02-03 2004-06-29 Novartis Ag Benzo-oxadiazoles, -thiadiazoles and -1,4-diazines, pharmaceutical compositions containing them and a process for preparing them
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
BR0317168A (pt) * 2002-12-13 2005-11-01 Neurogen Corp Composto ou uma forma farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de reduzir condutância de cálcio de um receptor de capsaicina celular, e de inibir ligação de ligante vanilóide a um receptor de capsaicina, métodos de tratar uma condição responsiva à modulação de receptor de capsaicina, dor, coceira, tosse ou soluços, incontinência urinária, de promover perda de peso em paciente, e de determinar a presença ou ausência de receptor de capsaicina em uma amostra, preparação farmacêutica embalada, e, uso de um composto
US20070082920A1 (en) * 2005-10-06 2007-04-12 Yongsheng Song NAD+-dependent DNA ligase inhibitors
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
DE102006026583A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
CN107405350A (zh) * 2016-02-04 2017-11-28 江苏恒瑞医药股份有限公司 一种含有吡啶并嘧啶类衍生物或其可药用盐的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3021332A (en) * 1954-01-04 1962-02-13 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making
GB1129084A (en) * 1965-02-18 1968-10-02 Wellcome Found Novel pyrido[2,3-d]pyrimidines
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3438351A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
ATE50407T1 (de) 1990-02-15
PT81860A (en) 1986-02-01
NO164353B (no) 1990-06-18
CA1276636C (en) 1990-11-20
PT81860B (pt) 1988-05-27
AU5219386A (en) 1986-07-24
FI81574C (fi) 1990-11-12
US4621082A (en) 1986-11-04
EP0189045A2 (de) 1986-07-30
JPS61167688A (ja) 1986-07-29
DE3669041D1 (de) 1990-03-22
FI860197A (fi) 1986-07-20
EP0189045B1 (de) 1990-02-14
DE3501696A1 (de) 1986-07-24
ZA86363B (en) 1986-09-24
CN1010947B (zh) 1990-12-26
GR860117B (en) 1986-05-16
FI860197A0 (fi) 1986-01-16
NO164353C (no) 1990-09-26
EP0189045A3 (en) 1988-10-05
DK23386A (da) 1986-07-20
ES8704491A1 (es) 1987-04-01
CN86100279A (zh) 1986-11-19
HUT40127A (en) 1986-11-28
HU195812B (en) 1988-07-28
NZ214842A (en) 1988-07-28
PH22610A (en) 1988-10-17
AU578783B2 (en) 1988-11-03
FI81574B (fi) 1990-07-31
ES551013A0 (es) 1987-04-01
DK23386D0 (da) 1986-01-17

Similar Documents

Publication Publication Date Title
DE10299021I2 (de) Piperazinyl-heterocyclische Derivate
FI873178A0 (fi) Dynamisk addresstranslator med hoeg hastighet och hoeg taethet.
DE3581407D1 (de) Bewahrung lebender gewebe.
NO855342L (no) Pyridoyrimidiner og fremgangsmaater for fremstilling derav.
DK65987D0 (da) 1,4-benzoxazinderivater eller syreadditionssalte deraf, fremgangsmaade til fremstilling af forbindelserne og forbindelsernes anvendelse
DK454086D0 (da) Quinolinderivater og deres anvendelse
ES550767A0 (es) Procedimiento para la obtencion de acidos 1-ciclopropil-1,4-dihidro-4-oxo-1,8 naftiridin-3-carboxilicos.
ES514340A0 (es) "procedimiento de obtencion de nuevos derivados de piperazina".
NO871912L (no) Fremgangsmaate for fremstilling av en animalsk celletransformant.
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
FI863657A0 (fi) Foerfarande foer framstaellning av n-sulfamyl-3-(2-guanidino-tiazol-4-yl-metyltio)-propionamidin.
ES538398A0 (es) Procedimiento para la obtencion de tiolan-2,4-dion-3-carboxamidas
ES542208A0 (es) Procedimiento para la obtencion de b-naftilalquilaminas
LV10153A (lv) Sastavs seklu dezinfekcijai
FI875337A (fi) Pulverformiga belaeggningshartser med svag glans och med hoeg slaghaollfasthet.
DK420187A (da) Oxiran-pseudooligosaccharider, deres fremstilling og anvendelse
DK204780A (da) 3-substituerede hexahydropyrimido (1,2-a) azepiner eller salte deraf deres fremstilling og anvendelse
DK343587A (da) Acylerede heterocycliske forbindelser
ES2037116T3 (es) Procedimiento para la obtencion de bencilaminoarildihidropiridinlactonas.
DE3049857A1 (de) Pre-coated body implant